Literature DB >> 36060520

ptk2 and mt2a Genes Expression in Gastritis and Gastric Cancer Patients with Helicobacter pylori Infection.

Manouchehr Ahmadi Hedayati1,2, Delniya Khani2, Farshad Sheikhesmaeili1, Bijan Nouri3.   

Abstract

Background: ptk2 and mt2a genes contribute to the cell cycle during proliferation and apoptosis, respectively. Designing a case-control study including gastric adenocarcinoma and gastritis patients with and without Helicobacter pylori infection would lead to determinate of the correlations between ptk2 and mt2a genes expression with H. pylori infection in gastric antral epithelial cells.
Methods: Overall, 50 and 30 gastric antral biopsy samples of gastric cancer (case group) and gastritis (control group) patients were included into study, respectively. All biopsy samples were collected considering the exclusion criteria including patients with a history of consumption of tobacco, alcohol, and anti-H. pylori drugs. Each patient group is divided into with and without H. pylori infection to detect cDNA fold changes of ptk2 and mt2a genes by using Real Time RT PCR. Furthermore, the presence of H. pylori virulence genes was detected directly by using specific primers and simple PCR on cDNA synthesized from total RNA of gastric antral biopsy samples.
Results: A negative correlation was revealed between age and clinical manifestations with the ΔCt value of the ptk2 gene (P < 0.05). The H. pylori iceA1/2 and cagE genes revealed positive and negative correlations with the ΔCt value of the ptk2 gene (P < 0.05), respectively. Furthermore, a weak correlation was detectable between H. pylori babA2/B, oipA, and cagY genes and the ΔCt value of the mt2a gene in gastric antral epithelial cells of patients (P < 0.1). Conclusions: The results of the current study opened a view for more investigation on the stunning roles of H. pylori infection in clinical outcomes through mt2a and ptk2 gene expression in gastric antral epithelial cells.
Copyright © 2022 Manouchehr Ahmadi Hedayati et al.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 36060520      PMCID: PMC9436627          DOI: 10.1155/2022/8699408

Source DB:  PubMed          Journal:  Can J Gastroenterol Hepatol        ISSN: 2291-2789


1. Introduction

In a close competition between carcinogenic agents and natural anti-cancer drugs such as Allium, cell signaling molecules are considered the effective targets [1]. In this regard, it has been revealed that the main pathways of natural anticancer drugs are to induce apoptosis by activating the MAPK and PI3K/AKT signaling pathways suppressing tumor growth [1]. In this meantime, Mt2a (Metallothionein 2A) as a member of the metallothionein proteins family contributes to critical roles including increasing intracellular concentration of heavy metals, protecting the cells against the toxicity of hydroxyl free radicals and heavy metals affecting cell apoptosis, proliferation, angiogenesis, and anti-inflammatory processes [2-4]. As a critical role in cell cycling, Metallothioneins control HMBOX1 (Homeobox containing 1) protein bound to the double-stranded repeat sequence of telomeres following regulation of zinc intracellular concentration [5-8]. Recent studies have shown that following LPS-induced inflammation and ROS production, HMBOX1 inhibits NF-κB and the MAPK signaling pathway [1, 9]. In this regard, MT2A protein exerts its anti-cancer effects through inactivation of NFKBIA (NFKB Inhibitor Alpha) subsequent binding to MZF1 (Myeloid Zinc Finger 1) [9, 10]. As a clinical impact of Mt2a, it has recently been shown that attenuation of MT2A and IkB-α gene expression in human gastric epithelial cells is associated with a poor prognosis in gastric cancer patients [9, 10]. Furthermore, some mt2a gene polymorphisms, including rs28366003 and rs1610216, are associated with an increased risk of cancer [11-13]. In this regard, some MT-2A gene polymorphisms are associated with adenocarcinoma risk in the Iranian patient population [14]. Moreover, in the Polish population, the rs28366003 SNP polymorphism has been associated with breast and prostate cancer [15]. On the other hand, the ptk2 gene encodes a cytoplasmic tyrosine kinase protein, namely, FAK (Focal Adhesion Kinase) [16-18]. The FAK/Paxillin signaling pathway conducts a substantial effect on the cell migration following activating SH2 domains of the Src kinase family and consequentially triggering downstream-activating signals leading to the regulation of cell motility, invasion, survival, and proliferation [19]. The changes in ptk2 gene expression are associated with the pathological stage, progression, and cancer's specific survival [20]. There is evidence to support the role of FAK in promoting malignant phenotypes (unregulated cell proliferation, survival, and migration) of various tumor cells in vitro [21, 22]. The ptk2 gene over-expression is commonly seen in metastatic cancers and is obviously associated with malignant clinical outcomes [23-25]. Furthermore, inhibitors of FAK kinase exert suppressing cancer cell growth in clinical trials [26-28]. In the other studies, the ptk2 gene over-expression is well-known as a pathological risk factor predicting aggressive biological behavior of bladder carcinoma cells [29]. Considering a previous study, FAK is highly expressed in human gastric cancer cells and correlated with tumor progression, invasion, and metastasis [30]. To conclude, the studies show that the Fak protein and its gene [ptk2] are significantly associated with cancer progression [31, 32]. H. pylori as the most common causative agent of chronic infections in humans shows a full long history related to clinical implications from gastritis to gastric cancer [33]. In this regard, the studies show that the H. pylori virulence factors have an indispensable impact on the clinical consequences of H. pylori persistent active infection [33-37]. In the meantime, the epidemiological studies show that H. pylori adhesins, including Sab, Bab, and the type 4 secretory system (T4SS), are related to peptic ulcers and gastric cancer [33-36]. CagA suppresses the apoptotic activity of VacA and activates the signaling pathway of the factor NF-KB inducing overexpression of anti-apoptotic agents [33]. On the other hand, CagY and CagL proteins, as the significant members of T4SS proteins with a tubular structure, following contact with gastric epithelial cell surface receptors, including beta-1 integrin receptors, inject CagA carcinogen protein into the gastric epithelial cell [37-40]. Therefore, it is worth to mention that despite the presence of the cagA gene in the H. pylori strains genome, due to possible changes in the cagY gene expression under the full stress environment of the stomach, the CagA protein could not be able to inject into host cells [39]. This study investigated the correlation between the H. pylori virulence genes and ptk2 and mt2a genes expression in gastric antral epithelial cells of gastritis and gastric cancer patients with H. pylori infection.

2. Materials and Methods

2.1. Sampling

A case-control study was designed on patients who had involved gastric adenocarcinoma and gastritis [41, 42]. Considering the prevalence of gastric adenocarcinoma and H. pylori infection in Sanandaj city, located in the west of Iran, using Cochran's formula, 30 and 50 patients with gastric adenocarcinoma and gastritis were registered [42]. Patients with a history of anti-H. pylori chemotherapy, alcohol, and cigarette consumption were excluded from the study. According to the study's aim, to investigate H. pylori infection's effect on the mt2a and ptk2 genes expression, the gastric biopsy samples were collected from patients referred to Tohid Hospital in Sanandaj city. The H. pylori active infection was detected by using a urea breath test [43, 44]. Two gastric biopsy specimens were obtained from each patient by a gastroenterologist. One biopsy sample was prepared from the gastric antrum, the natural site of H. pylori infection, to detect H. pylori virulence genes and study mt2a and ptk2 gene expression using PCR, and another biopsy from the gastric adenocarcinoma tumor area to pathologic evaluation. The gastric antral biopsy sample for molecular analysis was immediately dropped into RNA Later solution and transferred to the Molecular Microbiology Laboratory of Kurdistan University of Medical Sciences. On the other hand, the gastric tumor area biopsy samples including cardia, body, or pyloric area, were evaluated at the pathology center of Tohid Hospital.

2.2. PCR

First of all, total RNA was extracted from gastric antral biopsy samples (Miniprep Kit; Bio Basic Company, Toronto, Canada) and immediately converted to cDNA (Prime Script TM RT-PCR Kit; Takara Company, Japan). To survey the presence of the H. pylori genome in gastric antral biopsy samples, H. pylori 16s rRNA gene-specific primer and PCR method were used. Primers of H. pylori virulence genes were designed by using primer3 online software and blast on the PubMed website and then were synthesized by Bioneer company (South Korea; Tables 1 and 2). The thermocycler program was set based on the current protocols. Using Takara kits (Emerald Amp® MAX PCR Master Mix), PCR master mix was prepared. Single PCR steps were performed according to the current PCR protocols and using annealing temperatures of primers in a final volume of 25 microliter (Eppendorf® Co.; Tables 1 and 2) (17). Based on agarose gel electrophoresis protocols, PCR products were run on 1% agarose gel to observe PCR results. To prove the H. pylori genome, the H. pylori vacA m2 gene was sequenced and registered in the GenBank with accession number MK642592.1.
Table 1

Primers of H. pylori T4SS, 16s rDNA, and vacA in simple PCR.

Specific primersSequenceAnnealing Tm°CProduct size bpReference
16s rDNA H. pylori F16s rDNA H. pylori RCTGGAGAGACTAAGCCCTCCAGGATCAAGGTTTAAGGATT50446This study

cagA FcagA RTGACCAACAACCACAAACCGTCAGGATCGTATGAAGCGACAG57108This study

cagA EPIYA-C FcagA EPIYA-C RAAGAAAGCAGGACAAGCAGCCTAACCGATCGCCCTACCTT55188This study

cagT FcagT RAGGGTGTGGTGATGATAGCGTGCTTGTTGTTTGCTCCACT55154This study

cagE FcagE RGAATGGAGCGAGCGATGAAATAGGAATTTGCAGCGCTCAC56163This study

cagY FcagY RAGTTCAAGTGGCGCTAGATTGACAAGCCTTTCAAGCATTCGT57200This study

vacA s1/s2 FvacA s1/s2 RATGGAAATACAACAAACACACCTGCTTGAATGCGCCAAAC55259/286Atherton et al. [46]

vacA m1/m2 FvacA m1/m2 RTGGATAGTGCGACTGGGTTTTCCATGCGGTTGTTGTTGTT54205/220This study

The primers yield various fragments of vacA depending on the presence of a repetitive nucleotides sequence in some vacA alleles.

Table 2

Primers of H. pylori adhesins and surface proteins.

Specific primersSequenceAnnealing Tm°CProduct size bpReference
iceA1 FiceA1 RGTGTTTTTAACCAAAGTATCCTATAGCCASTYTCTTTGCA45247Van Doorn et al. [47]

iceA2 FiceA2 RGTTGGGTATATCACAATTTATTTRCCCTATTTTCTAGTAGGT47229/234Van Doorn et al. [47]

hopQI FhopQI RACGAACGCGCAAAAACTTTATTGCCATTCTCATCGGTGTA55187Sicinschi et al. [48]

hopQII FhopQII RACAGCCACTCCAATCCAGAAAACCCCACCGTGGATTTTAG55160Sicinschi et al. [48]

babA2 FbabA2 RCAATGCGGTGCGTGAAAATCATACCCTGGCTCGTTGTTGA57205This study

babB FbabB RCAATTCCCCGGCGTATCAAGATTGCAAGTGATGGTCGTCG56175This study

sabA FsabA RTCTCTCGCTTGCGGTATCATAGCTCAATGTTGTTGGCGTT56204This study

sabB FsabB RGCATTCAAACGGCGAACAACTCCTGTGCAGTTCCCATCTT56248This study

alpA FalpA RCGCTCCTATCAAAACCGCTCTTCCCGTCCAACTTACCGAA55185This study

alpB FalpB RTCAACTTGCGAGCAGACCTAAGCCATAGACCCCATACACG57218This study

oipA FoipA RCTCCACGCTGAAAGGAATGGCCATTTCCTGCGAATCGGTT55233This study

2.3. Real-Time RT PCR

To detect mt2a and ptk2 genes' expression in the gastric biopsy samples by using the Real-Time RT PCR method (Corbett machine, Co.), the specific primers of mt2a and ptk2 as the target genes and GAPDH as the internal genes were designed by using primer3 software and their genes sequences in the GenBank (Table 3). Takara kits (Emerald Amp® MAX PCR Master Mix) were used to prepare the PCR master mix. The PCR amplification program included a 10 minutes denaturation step at 95°C and 40 cycles of denaturation at 95°C for 15 seconds, specific annealing temperatures for 30 seconds, and extension at 72°C for 60 seconds. The relative quantity of the mt2a and ptk2 genes expression in gastritis (control group) and gastric adenocarcinoma (case group) patients were calculated by ΔCt (threshold cycle) = Ct (DNMT1) Ct (GAPDH). The mean of Ct of each 3 PCR reactions was put on the ΔΔCt formula to compute the fold change of each gene in the case and control groups by using the 2−ΔCt formula [43-45].
Table 3

Specific Primers of ptk2 and mt2a in Real-Time RT PCR.

Specific primersSequenceAnnealing Tm°CProduct size bpReference
GAPDH FGAPDH RGAAGGTGAAGGTCGGAGTCAACCAGAGTTAAAAGCAGCCCTGGT6071
ptk2 Fptk2 RGCACCCACCGAGAGATTGAGGGGCCAGTTTCATCTTGTTGA6081[49]
mt2a Fmt2a RGCCCAGGGCTGCATCTGTTTGTGGAAGTCGCGTTCTTTA60102[50]

2.4. Statistical Analyses

Quantitative and qualitative data analysis was performed using SPSS software version 26. Crosstab chi-square tests were used to survey the correlation and relationship between qualitative data [41, 42]. First, the quantitative data distribution status was determined using Kolmogorov–Smirnov statistical test [42]. The distribution of mt2a and ptk2 genes ΔCt was abnormal. Accordingly, Mann–Whitney and Kruskal–Wallis tests were used to investigate the correlation between quantitative data and comparison in the case and control groups and subgroups [42]. The significance level was considered less than 0.05 [41].

3. Results

Based on the urea breath test results, 46% and 36.66% of gastritis and gastric adenocarcinoma patients showed H. pylori active infection, respectively (Table 4). It revealed that because of an anti-H. pylori drug without medical registration, the prevalence of H. pylori active infection among gastric adenocarcinoma patients was significantly lower than in gastritis patients (Table 4). Like in the previous studies, the frequency of H. pylori infection and gastric adenocarcinoma increased along with increasing age (P < 0.001; Tables 4 and 5).
Table 4

Demographic data of patients.

GastritisGastric cancerTotal P value
H. pylori infection (positive/negative)23/2711/1934/460.487
Sex (male/female)24/2624/648/320.024
Age group (18–30/31–45/46–60/61–85)10/18/17/50/0/7/2310/18/24/280.005
Table 5

The frequency of H. pylori infection among males and females in various age groups.

H. pylori infectionSex (n: 80)Age group (n: 80)
MaleFemale18–3031–4546–6061–85
H. pylori infection (positive, n: 34)19152101111
H. pylori infection (negative, n: 47)2917881317
Total483210182428
Besides the genetic factors, exposure to environmental carcinogens factors, diet and H. pylori infection contribute to increasing gastric cancer risk [43, 44]. In this regard, although the results of the current study showed that the prevalence of gastric adenocarcinoma is significantly higher in men (P < 0.05; Table 4), it is worthy of note that this significant difference was not related to H. pylori infection (Table 5). The changes of ptk2 and mt2a genes ΔCt in demographic subgroups indicated a negative correlation between ptk2 gene ΔCt with patients' age and clinical manifestations (Table 6 and Figure 1). This means that the ptk2 gene expression in gastric antral epithelial cells increases with getting older and gastric cancer up 2.51 and 4.32 times, respectively (P < 0.005). In addition, a significant decrease of ΔCt of the ptk2 gene was revealed in patients with H. pylori cagE+ strains infection (Table 7). In these cases, ptk2 gene expression increased 5.06-fold compared to cagE− samples (P < 0.05; Table 8). On the other hand, gastric antral biopsies with infection of H. pylori iceA1/2+ strains showed a positive correlation with the ΔCt of the ptk2 gene (P < 0.005). In samples with iceA1/2 cDNA, the expression level of the ptk2 gene increased by 7.66-fold than in samples with iceA2+ cDNA (P < 0.005).
Table 6

Correlations between ptk2 and mt2a ΔCt and patients' demographic characters.

SexAge groupDisease H. pylori infectionGastric cancer areaTumor grade
ptk2 correlationP value0.0800.589−0.3340.002−0.3790.0010.0420.779−0.1070.6360.3450.116
mt2a correlationP value0.1460.323−0.0550.710−0.1040.482−0.0490.7420.0410.8580.2570.248
Figure 1

A simple scatter plot of ΔCt of the ptk2 gene depicts a reverse relationship with R2 linear 0.057. This means the ptk2 gene expression will increase along with increasing age.

Table 7

Correlations between ptk2 and mt2a ΔCt and gene expression of H. pylori virulence genes in gastric antral epithelial cells of gastritis and gastric adenocarcinoma patients.

vacA s1m1/s1m2 cagA cagA- EPEAYC cagT cagY cagE sabA/B babA2/B hopQI/II alpA/B oipA iceA1/2
ptk2 correlationP value0.3200.065−0.2160.312−0.1560.468−0.0820.804−0.2380.262−0.3900.023−0.2150.3140.1920.370−0.1920.3680.1860.3840.1520.4720.5190.002
mt2a correlationP value−0.2560.2270.2920.1660.3040.1490.0090.966−0.3780.0680.2890.171−0.3670.087−0.3880.0610.0400.854−0.0930.665−0.3480.095−0.2930.165
Table 8

The statistical relationships of ptk2 genes expression with H. pylori infection and its virulence genes expression using Mann–Whitney U test. Fold changes of ptk2 gene expression were calculated by using the average of ptk2 ΔCt in the case and control groups (P < 0.05).

N Mean rank Z P valueMean ΔCt ptk2Fold change
DiseaseAdenocarcinomaGastritis305029.2047.28−3.3710.0015.47306.80482.51
Age group61–8531–45281818.4831.31−3.1630.0025.62037.73544.32
iceA1/2 iceA2iceA1/2 171712.4122.59−2.9830.0024.87197.80937.66
cagE PositiveNegative5298.319.09−2.2390.0234.34606.68455.06
Although no correlation was observed between H. pylori infection and ΔCt of ptk2 and mt2a genes, a weak correlation was observed between mt2a gene ΔCt and subgroups with babA2/B, oipA, and cagY cDNA (P < 0.1; Table 9). In samples with babA2/B cDNA, the expression of the mt2a gene increased 5.14-fold than in samples with babA2/B cDNA (P < 0.005; Table 9).
Table 9

The statistical results of mt2a gene expression with H. pylori infection and its virulence genes expression using Mann–Whitney U test. Fold changes of mt2a gene expression were calculated by using the average of mt2a ΔCt in the case and control groups (P < 0.01).

N Mean rank Z P valueMean ΔCt mt2aFold change
babA2/B NegativebabA2/B17 39.083.67−1.8760.0615.37673.01675.14

oipA NegativePositive3 3120.5011.77−1.6710.0956.13004.69182.71

cagY CagY-MRR negative13 219.4014.71−1.8150.0684.14905.28502.2

4. Discussion

MT2A, as an oxidative shock protein protecting cell DNA, influences the cell cycle through apoptosis [2-4]. Pan et al. showed that overexpression of the mt2a gene is associated with increasing tumor grade and poor gastric cancer prognosis [10]. They showed that MT2A induces apoptosis by stopping the G2/M phase of the cell cycle, and the effect of MT2A on apoptosis is due to the suppression of the NF-KB signaling pathway [9, 10]. Wang et al. showed that MT2A increases the expression of P21 and BAX proteins by affecting P53 which is a pre-apoptotic protein triggering the cell death process [12]. Previous studies show the positive correlations between mt2a gene polymorphisms and breast, liver, and prostate cancers [11-15]. In a comparison, the results of the current study showed no statistically significant correlation between mt2a gene ΔCt and patients' demographic characteristics, including clinical manifestations, tumor grade, adenocarcinoma tumor area, age, sex, and H. pylori infection (Table 5). On the other hand, weak and negative correlations were observed between the cDNA of babA2/B, oipA, and cagY virulence genes of H. pylori with mt2a gene ΔCt (P < 0.1; Table 7). The mt2a gene expression in gastric biopsy samples with H. pylori babA2/B cDNA was higher up to 5.14-fold than in biopsy samples with H. pylori babA2/B cDNA (Table 9). These results indicate that the simultaneous expression of H. pylori babA2 and babB genes (babA2/B cDNA) correlates weakly with increased mt2a gene expression (P < 0.1). Furthermore, previous studies have shown the negative and positive correlations between gastric cancer with H. pylori babA2/B and cagE, cagA, and iceA1 genes expression, respectively (Table 9). Aras et al. showed that the cagY gene has two reproducible and variable regions at the 5′ end sequence including forward (FRR) and middle (MRR) [38]. They showed that following an increase or decrease in the copy number of reproducible sequences, the cagY gene expression and consequently CagY protein's efficiency to bind to β1 integrin receptors of gastric epithelial cells will change [38]. They revealed that changes in the CagY protein antigens would give a trait to bacteria to escape from the gastric mucosal immune system and establish a persistent infection [38]. The present study showed a statistically weak correlation between the H. pylori cagY gene with the MRR region and increased mt2a gene expression up to 2.2 times (P < 0.1; Table 9). The mt2a gene expression in the biopsy specimens with the H. pylori cagY-MRR+ cDNA was higher than in the biopsy specimens with the H. pylori cagY-MRR− cDNA (P < 0.1). FAK protein is known as a tyrosine kinase integrin that its gene expression will increase along with cancer progression [19-22]. Some studies have shown a gradual increase in FAK protein (ptk2 gene) related to poor cancer prognosis [29]. Zhang et al. showed a high ptk2 gene expression correlated with aggressive traits of bladder squamous cell carcinoma [29]. Their Kaplan–Meyer analysis also showed a correlation between ptk2 gene expression and the pathological stages, invasion of the disease, and reduced chance of survival in carcinoma [29]. The present study showed that the ptk2 gene expression and the frequency of gastric cancer increase along with increasing age (P < 0.001). Previous studies, based on the bacterial effects on the host cytoskeleton, show Hijacking of the FAK/Paxillin pathway to control cell physiological trends [51]. In this regard, Kim et al. showed following being attached Shigella flexneri OspE protein to integrin-binding kinase, the integrin B1 gene expression will be increasing, and suppression occurs as a result of phosphorylation of FAK and Paxillin [51].

5. Conclusion

In a remarkable conclusion, this study showed that the gastric antral epithelial samples with infection of H. pylori iceA1/2 and cagE genotypes reveal a strong correlation with increased ptk2 gene expression (P < 0.001).
  48 in total

1.  Non-invasive genotyping of Helicobacter pylori cagA, vacA, and hopQ from asymptomatic children.

Authors:  Liviu A Sicinschi; Pelayo Correa; Luis E Bravo; Richard M Peek; Keith T Wilson; John T Loh; Maria C Yepez; Benjamin D Gold; Dexter T Thompson; Timothy L Cover; Barbara G Schneider
Journal:  Helicobacter       Date:  2012-04       Impact factor: 5.753

2.  Overexpression of enhancer of zeste homolog 2 (EZH2) and focal adhesion kinase (FAK) in high grade endometrial carcinoma.

Authors:  Jun Zhou; Ju-Won Roh; Sudeshna Bandyopadhyay; Zhengming Chen; Adnan R Munkarah; Yaser Hussein; Baraa Alosh; Tarek Jazaerly; Kinda Hayek; Assaad Semaan; Anil K Sood; Rouba Ali-Fehmi
Journal:  Gynecol Oncol       Date:  2012-08-04       Impact factor: 5.482

3.  Expression of ASAP1 and FAK in gastric cancer and its clinicopathological significance.

Authors:  Qiong Luo; Suyun Zhang; Donghuan Zhang; Fang Yuan; Xiangqi Chen; Sheng Yang
Journal:  Oncol Lett       Date:  2020-05-13       Impact factor: 2.967

Review 4.  Role of the cag-pathogenicity island encoded type IV secretion system in Helicobacter pylori pathogenesis.

Authors:  Nicole Tegtmeyer; Silja Wessler; Steffen Backert
Journal:  FEBS J       Date:  2011-02-25       Impact factor: 5.542

Review 5.  Focal adhesion kinase and its potential involvement in tumor invasion and metastasis.

Authors:  L J Kornberg
Journal:  Head Neck       Date:  1998-12       Impact factor: 3.147

6.  How to choose the right statistical test?

Authors:  Barun K Nayak; Avijit Hazra
Journal:  Indian J Ophthalmol       Date:  2011 Mar-Apr       Impact factor: 1.848

7.  Metallothionein 2A genetic polymorphisms and risk of ductal breast cancer.

Authors:  Anna Krześlak; Ewa Forma; Paweł Jóźwiak; Agnieszka Szymczyk; Beata Smolarz; Hanna Romanowicz-Makowska; Waldemar Różański; Magdalena Bryś
Journal:  Clin Exp Med       Date:  2012-10-06       Impact factor: 3.984

8.  Focal adhesion kinase overexpression and its impact on human osteosarcoma.

Authors:  Ke Ren; Xiao Lu; Nan Yao; Yong Chen; Aizhen Yang; Hui Chen; Jian Zhang; Sujia Wu; Xin Shi; Chen Wang; Xiaoliang Sun
Journal:  Oncotarget       Date:  2015-10-13

9.  In silico and experimental analyses predict the therapeutic value of an EZH2 inhibitor GSK343 against hepatocellular carcinoma through the induction of metallothionein genes.

Authors:  Tsang-Pai Liu; Yi-Han Hong; Kwang-Yi Tung; Pei-Ming Yang
Journal:  Oncoscience       Date:  2016-01-29

10.  Protein tyrosine kinase 2: a novel therapeutic target to overcome acquired EGFR-TKI resistance in non-small cell lung cancer.

Authors:  Xuexia Tong; Ryosuke Tanino; Rong Sun; Yukari Tsubata; Tamio Okimoto; Mayumi Takechi; Takeshi Isobe
Journal:  Respir Res       Date:  2019-12-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.